LAURUSLABSNSELAURUS LABS LIMITED· Pharmaceuticals & BiotechnologyHighPositive
Announced Thu, 29 Oct, 2026 · 15:14 IST

Laurus Labs approves interim dividend of Rs 1 per share

LAURUSLABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+2.8%Reaction day
₹2181.90
prior close
₹2236.00
announcement price
In-mkt
timing
Nifty Midcap 150market+0.9%+2.0% vs market
Pharmaceuticals peers, median of 171sector+0.4%+2.5% vs sector

On the reaction day the stock moved 2.0 pts more than Nifty Midcap 150 and 2.5 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.1
15m
+0.4
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+2.8+0.9+2.0+0.4+2.5
Next day
+10.2pendingpending-0.7+10.9
2d
—————
3d
—————
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 171Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The board approved an interim dividend of Rs 1 per equity share, equal to 50% of the Rs 2 face value, for FY 2026-27. The record date is November 6, 2026, and dividend payments will begin on or after November 19, 2026.

Likely market impact

Eligible shareholders will receive Rs 1 per share in cash, providing a shareholder return and potentially supporting market sentiment.